Eugia receives FDA approval for Fondaparinux Sodium Injection!
Published: January 02, 2018
On December 27, 2017 Eugia received FDA approval for Fondaparinux Sodium Injection which is used to prevent deep vein thrombosis (DVT).
This approved product has an estimated market size of $73 million for the twelve months ending October 2017 according to IMS.